These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

596 related articles for article (PubMed ID: 27487743)

  • 1. High Prevalence of Acute Exacerbation of Interstitial Lung Disease in Japanese Patients with Systemic Sclerosis.
    Tomiyama F; Watanabe R; Ishii T; Kamogawa Y; Fujita Y; Shirota Y; Sugimura K; Fujii H; Harigae H
    Tohoku J Exp Med; 2016 Aug; 239(4):297-305. PubMed ID: 27487743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical characteristics and survival in systemic sclerosis-related pulmonary hypertension associated with interstitial lung disease.
    Launay D; Humbert M; Berezne A; Cottin V; Allanore Y; Couderc LJ; Bletry O; Yaici A; Hatron PY; Mouthon L; Le Pavec J; Clerson P; Hachulla E
    Chest; 2011 Oct; 140(4):1016-1024. PubMed ID: 21474572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interstitial lung disease increases mortality in systemic sclerosis patients with pulmonary arterial hypertension without affecting hemodynamics and exercise capacity.
    Michelfelder M; Becker M; Riedlinger A; Siegert E; Drömann D; Yu X; Petersen F; Riemekasten G
    Clin Rheumatol; 2017 Feb; 36(2):381-390. PubMed ID: 28028682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The potential utility of anterior upper lobe honeycomb-like lesion in interstitial lung disease associated with connective tissue disease.
    Yamakawa H; Ogura T; Sato S; Nishizawa T; Kawabe R; Oba T; Kato A; Horikoshi M; Akasaka K; Amano M; Kuwano K; Sasaki H; Baba T; Matsushima H
    Respir Med; 2020 Oct; 172():106125. PubMed ID: 32911135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pulmonary Artery Dimensions as a Prognosticator of Transplant-Free Survival in Scleroderma Interstitial Lung Disease.
    Gleason JB; Patel KB; Hernandez F; Hadeh A; Highland KB; Rahaghi F; Mehta JP
    Lung; 2017 Aug; 195(4):403-409. PubMed ID: 28456874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence Rate and Prevalence of Systemic Sclerosis and Systemic Sclerosis-Associated Interstitial Lung Disease in Japan: Analysis Using Japanese Claims Databases.
    Kuwana M; Saito A; Sakamoto W; Raabe C; Saito K
    Adv Ther; 2022 May; 39(5):2222-2235. PubMed ID: 35316503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved transplant-free survival in patients with systemic sclerosis-associated pulmonary hypertension and interstitial lung disease.
    Volkmann ER; Saggar R; Khanna D; Torres B; Flora A; Yoder L; Clements PJ; Elashoff RM; Ross DJ; Agrawal H; Borazan N; Furst DE; Saggar R
    Arthritis Rheumatol; 2014 Jul; 66(7):1900-8. PubMed ID: 24729406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Registry of the Spanish network for systemic sclerosis: clinical pattern according to cutaneous subsets and immunological status.
    Simeón-Aznar CP; Fonollosa-Plá V; Tolosa-Vilella C; Espinosa-Garriga G; Ramos-Casals M; Campillo-Grau M; García-Hernández FJ; Castillo-Palma MJ; Sánchez-Román J; Callejas-Rubio JL; Ortego-Centeno N; Egurbide-Arberas MV; Trapiellla-Martínez L; Gallego-Villalobos M; Sáez-Comet L; Velilla-Marco J; Camps-García MT; de Ramón-Garrido E; Esteban Marcos EM; Pallarés-Ferreres L; Hidalgo-Tenorio C; Sabio-Sánchez JM; Gómez-de la Torre R; Salvador-Cervello G; Rios-Blanco JJ; Gil-Aguado A; Vilardell-Tarrés M
    Semin Arthritis Rheum; 2012 Jun; 41(6):789-800. PubMed ID: 22169458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical algorithms for the diagnosis and prognosis of interstitial lung disease in systemic sclerosis.
    Hax V; Bredemeier M; Didonet Moro AL; Pavan TR; Vieira MV; Pitrez EH; da Silva Chakr RM; Xavier RM
    Semin Arthritis Rheum; 2017 Oct; 47(2):228-234. PubMed ID: 28454677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. All-cause Healthcare Costs and Mortality in Patients with Systemic Sclerosis with Lung Involvement.
    Fischer A; Kong AM; Swigris JJ; Cole AL; Raimundo K
    J Rheumatol; 2018 Feb; 45(2):235-241. PubMed ID: 29142033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiographic fibrosis score predicts survival in systemic sclerosis-associated interstitial lung disease.
    Takei R; Arita M; Kumagai S; Ito Y; Tokioka F; Koyama T; Saito R; Nishimura K; Tokumasu H; Ishida T
    Respirology; 2018 Apr; 23(4):385-391. PubMed ID: 28925574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determinants of morbidity and mortality of systemic sclerosis in Canada.
    Al-Dhaher FF; Pope JE; Ouimet JM
    Semin Arthritis Rheum; 2010 Feb; 39(4):269-77. PubMed ID: 18706680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and risk factors for left ventricular diastolic dysfunction in a scleroderma cohort.
    Vemulapalli S; Cohen L; Hsu V
    Scand J Rheumatol; 2017 Jul; 46(4):281-287. PubMed ID: 27635465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival in pulmonary hypertension associated with the scleroderma spectrum of diseases: impact of interstitial lung disease.
    Mathai SC; Hummers LK; Champion HC; Wigley FM; Zaiman A; Hassoun PM; Girgis RE
    Arthritis Rheum; 2009 Feb; 60(2):569-77. PubMed ID: 19180517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival rate, causes of death, and risk factors in systemic sclerosis: a large cohort study.
    Li X; Qian YQ; Liu N; Mu R; Zuo Y; Wang GC; Jia Y; Li ZG
    Clin Rheumatol; 2018 Nov; 37(11):3051-3056. PubMed ID: 30225558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequency, proportion of PF-ILD, and prognostic factors in patients with acute exacerbation of ILD related to systemic autoimmune diseases.
    Enomoto N; Naoi H; Mochizuka Y; Isayama T; Tanaka Y; Fukada A; Aono Y; Katsumata M; Yasui H; Mori K; Karayama M; Hozumi H; Suzuki Y; Furuhashi K; Fujisawa T; Inui N; Nakamura Y; Suda T
    BMC Pulm Med; 2022 Oct; 22(1):387. PubMed ID: 36289542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interstitial lung disease in systemic sclerosis: data from the spanish scleroderma study group.
    Sánchez-Cano D; Ortego-Centeno N; Callejas JL; Fonollosa Plá V; Ríos-Fernández R; Tolosa-Vilella C; Espinosa-Garriga G; Colunga-Argüelles D; Egurbide-Arberas MV; Rubio-Rivas M; Freire M; Ríos-Blanco JJ; Trapiella-Martínez L; Rodríguez-Carballeira M; Marín-Ballvé A; Pla-Salas X; Simeón-Aznar CP
    Rheumatol Int; 2018 Mar; 38(3):363-374. PubMed ID: 29322341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical features and outcome of acute exacerbation in connective tissue disease-associated interstitial lung disease: A single-center study from India.
    Singh P; Thakur B; Mohapatra AK; Padhan P
    Int J Rheum Dis; 2019 Sep; 22(9):1741-1745. PubMed ID: 31328423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicting Mortality in Systemic Sclerosis-Associated Interstitial Lung Disease Using Risk Prediction Models Derived From Idiopathic Pulmonary Fibrosis.
    Ryerson CJ; O'Connor D; Dunne JV; Schooley F; Hague CJ; Murphy D; Leipsic J; Wilcox PG
    Chest; 2015 Nov; 148(5):1268-1275. PubMed ID: 25996795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Esophageal dilatation and interstitial lung disease in systemic sclerosis: A cross-sectional study.
    Richardson C; Agrawal R; Lee J; Almagor O; Nelson R; Varga J; Cuttica MJ; Dematte JD; Chang RW; Hinchcliff ME
    Semin Arthritis Rheum; 2016 Aug; 46(1):109-14. PubMed ID: 27033049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.